West Pharmaceutical Services, Inc. (WST)

Market Cap	17.33B
Revenue (ttm)	2.96B
Net Income (ttm)	487.70M
Shares Out	71.91M
EPS (ttm)	6.68
PE Ratio	36.05
Forward PE	34.41
Dividend	$0.88 (0.37%)
Ex-Dividend Date	Nov 12, 2025

Volume	445,205
Open	238.18
Previous Close	240.54
Day's Range	237.93 - 241.96
52-Week Range	187.43 - 352.33
Beta	1.05
Analysts	Buy
Price Target	332.50 (+37.98%)
Earnings Date	Jul 24, 2025

About WST

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1923
• Employees: 10,600
• Stock Exchange: NYSE
• Ticker Symbol: WST
• Website: https://www.westpharma.com

Financial Performance

In 2024, WST's revenue was $2.89 billion, a decrease of -1.92% compared to the previous year's $2.95 billion. Earnings were $492.70 million, a decrease of -16.97%.

Analyst Summary

According to 7 analysts, the average rating for WST stock is "Buy." The 12-month stock price target is $332.5, which is an increase of 37.98% from the latest price.

Price Target

$332.5

(37.98% upside)

Analyst Consensus: Buy